Lactobacillus plantarum 299v for C. diff Prevention in Hospitals
This chat explores whether Lactobacillus plantarum 299v effectively prevents C. diff infections in hospitalized patients. It reviews clinical evidence, identifies who benefits most (e.g., older adults on antibiotics), and discusses timing, strain specificity, and safety considerations.
I've heard that Lactobacillus plantarum 299v might help prevent C. diff infections in hospitals—does it actually work, and who benefits most from taking it?
Great question. Let me share what the research says.
Does Lactobacillus plantarum 299v prevent C. diff infections?
Pillser's research database does not have a dedicated entry for L. plantarum 299v and C. difficile infection specifically, but there is relevant context. There have been clinical trials investigating this strain for preventing Clostridioides difficile-associated diarrhea in hospitalized patients receiving antibiotics. One of the most cited studies—a randomized, double-blind, placebo-controlled trial by Kujawa-Szewieczek et al. (2015)—found that L. plantarum 299v significantly reduced the incidence of C. difficile-associated diarrhea in adult hospitalized patients on antibiotic therapy.
However, it's worth noting that the evidence base for any single probiotic strain preventing C. diff infection is not as robust as the evidence for multi-strain probiotics or Saccharomyces boulardii. Broader meta-analyses (e.g., Cochrane reviews) show that probiotics in general can reduce the risk of C. difficile-associated diarrhea by about 50–60% in hospitalized adults taking antibiotics, but results vary by strain, dose, and patient population.
Looking at Pillser's data on L. plantarum 299v more broadly, it does show beneficial effects on reducing diarrhea rate (2 studies, both beneficial) and reducing inflammation (2 studies, both beneficial), which are relevant mechanisms for gut protection during antibiotic use. The typical dose studied across health outcomes is 10¹⁰ CFU per day.
Who benefits most?
Based on the available evidence, the people most likely to benefit from L. plantarum 299v for C. diff prevention are:
- Hospitalized adults receiving broad-spectrum antibiotics — these patients have the highest risk of C. diff due to gut flora disruption.
- Older adults (≥65 years) in hospital settings — age is a major risk factor for C. diff infection.
- Patients with a history of prior C. diff infection — recurrence risk is high, and probiotics may help restore protective gut flora.
The strongest data for this specific strain comes from hospital settings, not community use.
Important considerations
- Timing matters: The probiotic is typically started within 12–24 hours of the first antibiotic dose and continued for the duration of antibiotic therapy (and sometimes for a week after).
- Strain specificity: Not all Lactobacillus strains work equally. Results with L. plantarum 299v are specific to this well-characterized strain.
- Safety: In hospitalized patients, probiotics should be used under medical supervision, particularly in immunocompromised individuals, where there is a small theoretical risk of probiotic sepsis.
If you'd like, I can also search for products containing Lactobacillus plantarum 299v on Pillser — would that be helpful?